China Vaccine Market

According to Renub Research's latest report, "China Vaccine Market, Size, Forecast 20232027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" the China Vaccine Market is estimated to reach US$ 12.16 Billion by 2027 at a CAGR of 4.52 Percent. Annually, Approx. 700 Million vaccine doses are produced in China, and this made China one of the largest producers of vaccines worldwide. China is preparing to supply the world with low–cost vaccines that accomplish all productiveness, safety, and quality concerns. Vaccines are made available through the government's EPI (Expanded Program on Immunization) at no charge for 14 years of age.

China's vaccine market is divided into public and private vaccine markets. The Public Market is classified as Category 1, whereas Private vaccines are included in Category 2. These government-purchased vaccines are called Category 1 under the Regulations on the Administration of Vaccines and Vaccination. Vaccines are among the most effective and costeffective tools to stop suffering and death, especially among children from infectious diseases.